1. Home >
  2. Companies >
  3. Acquired >
  4. Life Science >
  5. United States >
  6. New York >
  7. FermaVir Pharmaceuticals

FermaVir Pharmaceuticals Overview

Life ScienceCompany

Where is FermaVir Pharmaceuticals headquartered?

FermaVir Pharmaceuticals is headquartered in New York, New York.

What sector is FermaVir Pharmaceuticals in?

FermaVir Pharmaceuticals is a life science company.

FermaVir Pharmaceuticals, Inc.

420 Lexington Avenue Suite 445,
New York, New York 10170
United States,
www.fermavir.com

FermaVir Pharmaceuticals, Inc. is a biotechnology company that develops antiviral drugs and other treatments in underserved segments of the pharmaceutical development marketplace. FermaVir’s Intellectual Property portfolio includes a number of patent applications and a worldwide exclusive license for potential new drug treatments of infectious diseases. Among FermaVir's lead drug candidates is FV-100, a potential breakthrough antiviral treatment that has demonstrated powerful inhibitory activity and may have potential therapeutic benefit for the treatment of shingles, also known as herpes zoster.


Company Summary

SECTOR

Life Science


Try Mergr Free — See This and 220,677+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for FermaVir Pharmaceuticals

New York Companies , Life Science Companies , United States Companies , New York Life Science Companies , New York Life Science with Acquisitions , New York Life Science with Divestitures

Related Lists for New York Companies

Largest New York Companies , Acquisitive New York Companies , Recently Acquired New York Companies , Recently Sold New York Companies , Private New York Companies , Public New York Companies , Acquired New York Companies , PE Backed New York Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for United States Companies

Largest United States Companies , Acquisitive United States Companies , Recently Acquired United States Companies , Recently Sold United States Companies , Private United States Companies , Public United States Companies , Acquired United States Companies , PE Backed United States Companies
Mergr

Solution for

Product

Company

Legal